BURNETT JOSEPH sold $33K of CLPT (indirect holdings)
BURNETT JOSEPH (CEO and President) sold 1,843 indirectly-held shares of ClearPoint Neuro, Inc. (CLPT) at $17.94 on 2026-06-17 under a Rule 10b5-1 trading plan.
How this was made
The 30-second read
Why it matters
The newest disclosed fact is the June 17 open-market sale of 1,843 shares by CEO Joseph Burnett under a 10b5-1 plan, with post-sale holdings reported.
Market read
Primarily useful for tracking insider activity; likely limited trading impact absent additional company-specific catalysts.
What to watch
The sale is indirect and on a pre-arranged plan; without context on total planned volume and prior filings, the signal strength is uncertain.
Background
The article is an SEC Form 4 insider transaction disclosure for ClearPoint Neuro, Inc. (CLPT).
Ticker impact
ClearPoint Neuro CEO Joseph Burnett filed a Form 4 selling 1,843 shares at $17.94 on a 10b5-1 plan, reducing holdings to 191,388.
Low near-term impact; any reaction is likely muted given the pre-arranged 10b5-1 nature.
The filing is a disclosed insider transaction with a stated pre-arranged 10b5-1 plan; there is no accompanying operational, financial, or regulatory development in the text.
Market effects
Minimal—this is company-specific insider transaction data with no sector-wide read-across provided.
None indicated.
None indicated.
Counterpoint
Even 10b5-1 sales can coincide with periods of perceived valuation risk; traders may still watch for follow-on selling volume or clustering of insider actions.
Key entities
- issuerClearPoint Neuro, Inc.
Company whose Form 4 insider transaction is disclosed (CLPT).
- insiderJoseph Burnett
CEO and President; reported an indirect open-market sale under a 10b5-1 plan.